JavaScript scheint in Ihrem Browser deaktiviert zu sein. Sie müssen JavaScript in Ihrem Browser aktivieren, um alle Funktionen in diesem Shop nutzen zu können.
Burkitt's lymphoma
Established from the tumor mass of an African child with Burkitt lymphoma in 1967; cells express MYC mRNA
Homo sapiens Tissue:B lymphocyte Morphology:Lymphoblast; lymphoblastoid Properties: Single cells or small clusters in suspension Cytogenic data: Human hypodiploid karyotype with 4% polyploidy - 44(43-46)< 2n> X, -Y, -5, -6, +7, -10, -13, -21, +3mar, ins(1; ?)(p11; ?), ins(3)(q11q29), der(5)t(1; 5)(q25; q35), del(8)(p22), der(14)t(14; ?)(p11; ?), der(15)t(15; 21)(p11; q11) - a supernumerary ring or fragment present in 8% of cells - NAMALWA marker chromosomes present Patient: Female, African, 3 yrs of age Medium: RPMI-1640 Medium + 10% FBS + 10 mM HEPES + 1.0 mM sodium pyruvate Subculture: Cultures can be maintained by the addition of fresh medium or replacement of medium. Maintain at 0.5-1.5 x 10^6 cells/ml; split 1:2 to 1:3 every 2-3 days; subculture cells at 1 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: II [ Cells Contain Herpesvirus (EBV) and Squirrel monkey retrovirus (SMRV)] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
B lymphocyte Morphology:Lymphoblast; lymphoblastoid Properties: Single cells or small clusters in suspension Cytogenic data: Human hypodiploid karyotype with 4% polyploidy - 44(43-46)< 2n> X, -Y, -5, -6, +7, -10, -13, -21, +3mar, ins(1; ?)(p11; ?), ins(3)(q11q29), der(5)t(1; 5)(q25; q35), del(8)(p22), der(14)t(14; ?)(p11; ?), der(15)t(15; 21)(p11; q11) - a supernumerary ring or fragment present in 8% of cells - NAMALWA marker chromosomes present Patient: Female, African, 3 yrs of age Medium: RPMI-1640 Medium + 10% FBS + 10 mM HEPES + 1.0 mM sodium pyruvate Subculture: Cultures can be maintained by the addition of fresh medium or replacement of medium. Maintain at 0.5-1.5 x 10^6 cells/ml; split 1:2 to 1:3 every 2-3 days; subculture cells at 1 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: II [ Cells Contain Herpesvirus (EBV) and Squirrel monkey retrovirus (SMRV)] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Lymphoblast; lymphoblastoid Properties: Single cells or small clusters in suspension Cytogenic data: Human hypodiploid karyotype with 4% polyploidy - 44(43-46)< 2n> X, -Y, -5, -6, +7, -10, -13, -21, +3mar, ins(1; ?)(p11; ?), ins(3)(q11q29), der(5)t(1; 5)(q25; q35), del(8)(p22), der(14)t(14; ?)(p11; ?), der(15)t(15; 21)(p11; q11) - a supernumerary ring or fragment present in 8% of cells - NAMALWA marker chromosomes present Patient: Female, African, 3 yrs of age Medium: RPMI-1640 Medium + 10% FBS + 10 mM HEPES + 1.0 mM sodium pyruvate Subculture: Cultures can be maintained by the addition of fresh medium or replacement of medium. Maintain at 0.5-1.5 x 10^6 cells/ml; split 1:2 to 1:3 every 2-3 days; subculture cells at 1 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: II [ Cells Contain Herpesvirus (EBV) and Squirrel monkey retrovirus (SMRV)] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Single cells or small clusters in suspension Cytogenic data: Human hypodiploid karyotype with 4% polyploidy - 44(43-46)< 2n> X, -Y, -5, -6, +7, -10, -13, -21, +3mar, ins(1; ?)(p11; ?), ins(3)(q11q29), der(5)t(1; 5)(q25; q35), del(8)(p22), der(14)t(14; ?)(p11; ?), der(15)t(15; 21)(p11; q11) - a supernumerary ring or fragment present in 8% of cells - NAMALWA marker chromosomes present Patient: Female, African, 3 yrs of age Medium: RPMI-1640 Medium + 10% FBS + 10 mM HEPES + 1.0 mM sodium pyruvate Subculture: Cultures can be maintained by the addition of fresh medium or replacement of medium. Maintain at 0.5-1.5 x 10^6 cells/ml; split 1:2 to 1:3 every 2-3 days; subculture cells at 1 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: II [ Cells Contain Herpesvirus (EBV) and Squirrel monkey retrovirus (SMRV)] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Human hypodiploid karyotype with 4% polyploidy - 44(43-46)< 2n> X, -Y, -5, -6, +7, -10, -13, -21, +3mar, ins(1; ?)(p11; ?), ins(3)(q11q29), der(5)t(1; 5)(q25; q35), del(8)(p22), der(14)t(14; ?)(p11; ?), der(15)t(15; 21)(p11; q11) - a supernumerary ring or fragment present in 8% of cells - NAMALWA marker chromosomes present Patient: Female, African, 3 yrs of age Medium: RPMI-1640 Medium + 10% FBS + 10 mM HEPES + 1.0 mM sodium pyruvate Subculture: Cultures can be maintained by the addition of fresh medium or replacement of medium. Maintain at 0.5-1.5 x 10^6 cells/ml; split 1:2 to 1:3 every 2-3 days; subculture cells at 1 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: II [ Cells Contain Herpesvirus (EBV) and Squirrel monkey retrovirus (SMRV)] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Female, African, 3 yrs of age Medium: RPMI-1640 Medium + 10% FBS + 10 mM HEPES + 1.0 mM sodium pyruvate Subculture: Cultures can be maintained by the addition of fresh medium or replacement of medium. Maintain at 0.5-1.5 x 10^6 cells/ml; split 1:2 to 1:3 every 2-3 days; subculture cells at 1 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: II [ Cells Contain Herpesvirus (EBV) and Squirrel monkey retrovirus (SMRV)] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
RPMI-1640 Medium + 10% FBS + 10 mM HEPES + 1.0 mM sodium pyruvate Subculture: Cultures can be maintained by the addition of fresh medium or replacement of medium. Maintain at 0.5-1.5 x 10^6 cells/ml; split 1:2 to 1:3 every 2-3 days; subculture cells at 1 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: II [ Cells Contain Herpesvirus (EBV) and Squirrel monkey retrovirus (SMRV)] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Cultures can be maintained by the addition of fresh medium or replacement of medium. Maintain at 0.5-1.5 x 10^6 cells/ml; split 1:2 to 1:3 every 2-3 days; subculture cells at 1 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: II [ Cells Contain Herpesvirus (EBV) and Squirrel monkey retrovirus (SMRV)] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Complete culture medium supplemented with 5% (v/v) DMSO
II [ Cells Contain Herpesvirus (EBV) and Squirrel monkey retrovirus (SMRV)] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.
Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.
Arbeitsanleitung (Data Sheet) anfordern
Produkt-Datenblatt anfordern
Sicherheitsdatenblatt anfordern
Vergleichen
Auf den Wunschzettel
Angebot anfordern
Lieferzeit anfragen
Technische Frage stellen
Bulk-Anfrage stellen
sales@hoelzel.de
« Zurück
Pünktliche Lieferung zu Ihrem Wunschtermin und bei jeder 5. Bestellung 15% sparen.
Passwort vergessen?
Noch nicht registriert? Konto hier erstellen!